The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis
The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis
Drug monitoring -- Congresses : Adverse drug event reporting : the roles of consumers and health-care professionals : workshop summary / Jeffrey M. Drazen [and others], rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy ; Institute of Medicine of the National Academies
Drug Monitoring -- standards : Emerging safety science : workshop summary / Sally Robinson, Robert Pool, and Robert Giffin [rapporteurs] ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Drug monitoring -- United States -- Congresses : Building a national capability to monitor and assess medical countermeasure use during a public health emergency : going beyond the last mile: proceedings of a workshop / Morgan Boname, Theresa Wizemann, and Justin Snair, rapporteurs ; Board on Health and Science Policy, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine
Drug-nutrient interactions -- Catalogs. : Natural medicines comprehensive database / complied by the editors of, Pharmacist's Letter, Prescriber's Letter ; [editor, Jeff M. Jellin]
Drug Overdose -- drug therapy : The pharmacist's guide to opioid use disorders / [edited by] Merrill Norton ; contributing section editors, Jeffrey N. Baldwin, Michael G. O'Neil
Drug Overdose -- prevention & control : A public health guide to ending the opioid epidemic / Michael R. Fraser, Jay C. Butler, editors ; with Philicia Tucker, managing editor
Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information
Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information
Drug Packaging -- legislation & jurisprudence. : Child-resistant packaging : a symposium / sponsored by ASTM Subcommittee D-10.16 on Child-Resistant Packaging and Packaging Consistent with Poison Prevention Packaging Act of 1970 of ASTM Committee D-10 on Packaging, American Society for Testing and Materials, Philadelphia, Pa., 17-18 Sept. 1975
1976
1
Drug Packaging -- standards : Leachables and extractables handbook : safety evaluation, qualification, and best practices applied to inhalation drug products / edited by Douglas J. Ball [and others]
Containers, packaging, and packaging materials for drugs and BIOLOGICAL PRODUCTS. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. (From Code of Federal Regulations, 21 CFR 1 Section 210, 1993) DRUG LABELING is also available
Here are entered works on the description and/or the cultivation of medicinal plants. Works on the discipline of medical botany are entered under Botany, Medical